Sign Out
Use only when it is judged that the therapeutic benefit outweighs the risk to pregnant women or women who may be pregnant. The safety of administration during pregnancy has not been established.
It is desirable to avoid administration to lactating women etc., but in the case that administration becomes necessary, advise the patient to refrain from breastfeeding. Transfer to breastmilk has been reported in animal experiments (rats).
Continue with Google